# Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

> **NCT07707778** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **National Taiwan University Clinical Trial Center** · enrollment: 60 (estimated)

## Conditions studied

- Human Immunodeficiency Virus (HIV)
- Metabolic Dysfunction Associated Steatotic Liver Disease
- Dyslipidaemia
- Diabetes Mellitus
- Obesity & Overweight
- Metabolic Syndrome

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07707778
- **Lead sponsor:** National Taiwan University Clinical Trial Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-06-25
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07707778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07707778, "Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07707778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*